LexDanaLexDanabeta
Inventor

Zhi Hong

Inventor
Irvine, CA, US

Overview

42→
Patents
2001–2019
Patent span
Chemistry
Primary field (CPC C)

Patents· 42 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
A61KPreparations for medical, dental or toiletry purposes20%
C07HSugars6%
C07BGeneral methods of organic chemistry5%
C07CAcyclic or carbocyclic compounds5%
C12NMicroorganisms or enzymes5%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
C07KPeptides1%
H01JElectric discharge tubes or discharge lamps1%
PatentTitleYear
10,308,937Combination long acting compositions and methods for Hepatitis C201910,227,603Plants as functional microRNA and/or functional siRNA carriers, preparation methods and uses thereof20198,946,273'S-Triazolyl alpha-mercapto acetanilides as inhibitors of HIV reverse transcriptase'20158,829,052'Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK'20148,722,929'N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators'20148,716,318'Pyridone sulfonamides and pyridone sulfamides as MEK inhibitors'20148,552,043'N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]-p-amino benzoic acids as HIV reverse transcriptase inhibitors'20138,481,581'S-triazolyl α-mercaptoacetanilides as inhibitors of HIV reverse transcriptase'20138,354,532'Pyrrolo [2,3-D] pyrimidines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV'20138,324,223'Substituted thieno [2,3-d] pyrimidines as HIV inhibitors'20128,252,828'S-triazolyl α-mercapto acetanilides as inhibitors of HIV reverse transcriptase'20128,227,601'Diaryl-purines, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitor for treatment of HIV'20128,211,898'Substituted thieno[3,2-d]pyrimidines as HIV inhibitors'20128,106,205'N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]p-amino benzoic acids as HIV reverse transcriptase inhibitors'20128,101,799'Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK'20128,063,049'Inhibitors of MEK'20117,947,721'S-triazolyl α-mercaptoacetanilides as inhibitors of HIV reverse transcriptase'20117,897,624'Pyridone sulfonamides and pyridone sulfamides as MEK inhibitors'20117,842,836'N-aryl-N\'alkyl sulfamides as MEK inhibitors'20107,820,664'Inhibitors of MEK'20107,759,518'Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK'20107,692,371'Electrode for the source of field emitting electrons and a panel and a lighting apparatus thereof'20107,683,087'N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl] -p-amino benzoic acids as HIV reverse transcriptase inhibitors'20107,652,047'Phenylamino isothiazole carboxamidines as MEK inhibitors'20107,638,496'Nucleoside analogs with carboxamidine modified monocyclic base'20097,595,324'Substituted thieno[3,2-D]pyrimidines as HIV inhibitors'20097,435,752'N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]-p-amino benozioc acids as HIV reverse transcriptase inhibitors'20087,429,667'Phenylamino isothiazole carboxamidines as MEK inhibitors'20087,371,857'Synthesis for hydroxyalkylated heterocyclic bases'20087,247,621'Antiviral phosphonate compounds and methods therefor'20077,217,815'2-beta -modified-6-substituted adenosine analogs and their use as antiviral agents'20077,081,449'Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides'20066,989,451'Heterocyclic compounds and uses thereof'20066,967,075'HCV replicase complexes'20056,906,190'Inhibitors for de novo-RNA polymerases and methods of identifying targets for same'20056,833,361'Nucleosides having bicyclic sugar moiety'20046,831,069'Pyrrolo2,3-dpyrimidine nucleoside analogs'20046,815,542'Nucleoside compounds and uses thereof'20046,434,489'Compositions of hepatitis C virus NS5B polymerase and methods for crystallizing same'20026,326,137'Hepatitis C virus protease-dependent chimeric pestivirus'20016,322,966'Viral specific requirements for self-priming RNA replication of hepatitis C virus replicase'20016,297,005'De novo priming activity of hepatitis C virus replicase'2001

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2001–2002Based in Nanuet, NY, US· patent location history
2004–2009Based in Aliso Viejo, CA, US· patent location history
2008–2015Patents assigned to ARDEA BIOSCIENCES INC (17)· patent assignee history
2008–2015Based in Irvine, CA, US· patent location history
2009–2013Based in Chapel Hill, NC, US· patent location history
2010–2014Patents assigned to ARDEA BIOSCIENCES (5)· patent assignee history
2011–2015Patents assigned to HONG ZHI (14)· patent assignee history
2011–2015Patents assigned to KOH YUNG-HYO (10)· patent assignee history
2012–2015Patents assigned to GIRARDET JEAN-LUC (9)· patent assignee history
2019Based in Research Triangle Park, NC, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ARDEA BIOSCIENCES INC172008–2015
HONG ZHIself142011–2015
KOH YUNG-HYO102011–2015
GIRARDET JEAN-LUC92012–2015
ARDEA BIOSCIENCES52010–2014
Locations
LocationPatentsSpan
Irvine, California, US132008–2015
Chapel Hill, NC, US112009–2013
Aliso Viejo, California, US102004–2009
Nanuet, New York, US42001–2002
Research Triangle Park, NC, US12019